1. Home
  2. PALI vs CTHR Comparison

PALI vs CTHR Comparison

Compare PALI & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PALI
  • CTHR
  • Stock Information
  • Founded
  • PALI 1996
  • CTHR 1995
  • Country
  • PALI United States
  • CTHR United States
  • Employees
  • PALI N/A
  • CTHR N/A
  • Industry
  • PALI Biotechnology: Biological Products (No Diagnostic Substances)
  • CTHR Consumer Specialties
  • Sector
  • PALI Health Care
  • CTHR Consumer Discretionary
  • Exchange
  • PALI Nasdaq
  • CTHR Nasdaq
  • Market Cap
  • PALI 3.5M
  • CTHR 4.1M
  • IPO Year
  • PALI N/A
  • CTHR 1997
  • Fundamental
  • Price
  • PALI $2.52
  • CTHR $1.30
  • Analyst Decision
  • PALI Strong Buy
  • CTHR
  • Analyst Count
  • PALI 1
  • CTHR 0
  • Target Price
  • PALI $8.00
  • CTHR N/A
  • AVG Volume (30 Days)
  • PALI 198.8K
  • CTHR 19.6K
  • Earning Date
  • PALI 11-12-2024
  • CTHR 11-26-2024
  • Dividend Yield
  • PALI N/A
  • CTHR N/A
  • EPS Growth
  • PALI N/A
  • CTHR N/A
  • EPS
  • PALI N/A
  • CTHR N/A
  • Revenue
  • PALI N/A
  • CTHR $23,684,860.00
  • Revenue This Year
  • PALI N/A
  • CTHR $31.82
  • Revenue Next Year
  • PALI N/A
  • CTHR N/A
  • P/E Ratio
  • PALI N/A
  • CTHR N/A
  • Revenue Growth
  • PALI N/A
  • CTHR N/A
  • 52 Week Low
  • PALI $2.18
  • CTHR $1.18
  • 52 Week High
  • PALI $22.35
  • CTHR $4.90
  • Technical
  • Relative Strength Index (RSI)
  • PALI 38.02
  • CTHR 40.56
  • Support Level
  • PALI $2.20
  • CTHR $1.32
  • Resistance Level
  • PALI $2.71
  • CTHR $1.52
  • Average True Range (ATR)
  • PALI 0.31
  • CTHR 0.09
  • MACD
  • PALI -0.03
  • CTHR 0.02
  • Stochastic Oscillator
  • PALI 25.76
  • CTHR 35.56

About PALI Palisade Bio Inc.

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

About CTHR Charles & Colvard Ltd

Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.

Share on Social Networks: